Sign in

CIK 0000771856

  • Non-accelerated filer
  • Smaller reporting company

CHAMPIONS ONCOLOGY, INC.

Sign in to watch
Ticker
CSBR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
521401755
Phone
+1 410-369-0365
Business address
855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
Former names
CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
  1. 4 Open-market buy Director bought 5,000 shares at $6.22 ($31,100)
  2. 4 Open-market buy Director bought 1,500 shares at $5.95 ($8,925)
  3. 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
  4. 4 Open-market buy Director bought 1,100 shares at $6.41 ($7,051)
  5. 4 Open-market buy Director bought 1,530 shares at $6.48 ($9,914)
  6. 4 Open-market buy Director bought 2,000 shares at $6.47 ($12,940)
  7. 4 Open-market buy Director bought 2,500 shares at $6.30 ($15,750)
  8. 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
  9. 4 Open-market buy Director bought 5,000 shares at $5.65 ($28,250)
  10. 4 Open-market buy Director bought 5,000 shares at $5.28 ($26,400)
  11. 4 Open-market buy Director bought 4,018 shares at $5.51 ($22,139)
  12. 4 Open-market buy Director bought 5,000 shares at $5.51 ($27,550)
  13. 4 Open-market buy Director bought 3,812 shares at $5.50 ($20,966)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy CEO bought 12,382 shares at $4.04 ($49,969)
  20. 4 Option exercise Director acquired 16,667 shares (option exercise)

Page 3 of 13 · 245 filings